These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 29580304

  • 1. Impact of Discontinuing Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: An Interrupted Time Series Analysis.
    Bearman G, Abbas S, Masroor N, Sanogo K, Vanhoozer G, Cooper K, Doll M, Stevens MP, Edmond MB.
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):676-682. PubMed ID: 29580304
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Noninfectious Hospital Adverse Events Decline After Elimination of Contact Precautions for MRSA and VRE.
    Martin EM, Bryant B, Grogan TR, Rubin ZA, Russell DL, Elashoff D, Uslan DZ.
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):788-796. PubMed ID: 29745356
    [Abstract] [Full Text] [Related]

  • 4. Discontinuing MRSA and VRE contact precautions: Defining hospital characteristics and infection prevention practices predicting safe de-escalation.
    Martin EM, Colaianne B, Bridge C, Bilderback A, Tanner C, Wagester S, Yassin M, Pontzer R, Snyder GM.
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1595-1602. PubMed ID: 34847970
    [Abstract] [Full Text] [Related]

  • 5. Can we reduce contact precautions days for methicillin-resistant Staphylococcus aureus and vancomycin resistant Enterococcus infected patients?
    Thottacherry ED, Hassoun A.
    J Infect Public Health; 2020 Aug; 13(8):1118-1122. PubMed ID: 32336607
    [Abstract] [Full Text] [Related]

  • 6. Stopping the routine use of contact precautions for management of MRSA and VRE at three academic medical centers: An interrupted time series analysis.
    Haessler S, Martin EM, Scales ME, Kang L, Doll M, Stevens MP, Uslan DZ, Pryor R, Edmond MB, Godbout E, Abbas S, Bearman G.
    Am J Infect Control; 2020 Dec; 48(12):1466-1473. PubMed ID: 32634537
    [Abstract] [Full Text] [Related]

  • 7. A Multicenter Pragmatic Interrupted Time Series Analysis of Chlorhexidine Gluconate Bathing in Community Hospital Intensive Care Units.
    Dicks KV, Lofgren E, Lewis SS, Moehring RW, Sexton DJ, Anderson DJ.
    Infect Control Hosp Epidemiol; 2016 Jul; 37(7):791-7. PubMed ID: 26861417
    [Abstract] [Full Text] [Related]

  • 8. Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection.
    Mangini E, Segal-Maurer S, Burns J, Avicolli A, Urban C, Mariano N, Grenner L, Rosenberg C, Rahal JJ.
    Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1261-6. PubMed ID: 17926277
    [Abstract] [Full Text] [Related]

  • 9. The discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: Impact upon patient adverse events and hospital operations.
    Schrank GM, Snyder GM, Davis RB, Branch-Elliman W, Wright SB.
    BMJ Qual Saf; 2020 Oct; 29(10):1-2. PubMed ID: 31320496
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of Contact Precautions to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Intensive Care Units.
    Khader K, Thomas A, Huskins WC, Stevens V, Keegan LT, Visnovsky L, Samore MH.
    Clin Infect Dis; 2021 Jan 29; 72(Suppl 1):S42-S49. PubMed ID: 33512528
    [Abstract] [Full Text] [Related]

  • 11. Intervention to reduce transmission of resistant bacteria in intensive care.
    Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA, STAR*ICU Trial Investigators.
    N Engl J Med; 2011 Apr 14; 364(15):1407-18. PubMed ID: 21488763
    [Abstract] [Full Text] [Related]

  • 12. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.
    Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES.
    Crit Care Med; 2009 Jun 14; 37(6):1858-65. PubMed ID: 19384220
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Bardossy AC, Alsafadi MY, Starr P, Chami E, Pietsch J, Moreno D, Johnson L, Alangaden G, Zervos M, Reyes K.
    Am J Infect Control; 2017 Dec 01; 45(12):1369-1371. PubMed ID: 28843943
    [Abstract] [Full Text] [Related]

  • 14. Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients.
    Kassakian SZ, Mermel LA, Jefferson JA, Parenteau SL, Machan JT.
    Infect Control Hosp Epidemiol; 2011 Mar 01; 32(3):238-43. PubMed ID: 21460508
    [Abstract] [Full Text] [Related]

  • 15. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Morgan DJ, Murthy R, Munoz-Price LS, Barnden M, Camins BC, Johnston BL, Rubin Z, Sullivan KV, Shane AL, Dellinger EP, Rupp ME, Bearman G.
    Infect Control Hosp Epidemiol; 2015 Oct 01; 36(10):1163-72. PubMed ID: 26138329
    [Abstract] [Full Text] [Related]

  • 16. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia.
    Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, Platt R.
    Clin Infect Dis; 2006 Oct 15; 43(8):971-8. PubMed ID: 16983607
    [Abstract] [Full Text] [Related]

  • 17. Does the removal of contact precautions for MRSA and VRE infected patients change health care-associated infection rate?: A systematic review and meta-analysis.
    Kleyman R, Cupril-Nilson S, Robinson K, Thakore S, Haq F, Chen L, Oyesanmi O, Browning K, Pino J, Mhaskar R.
    Am J Infect Control; 2021 Jun 15; 49(6):784-791. PubMed ID: 33276000
    [Abstract] [Full Text] [Related]

  • 18. Comparison of surveillance and clinical cultures to measure the impact of infection control interventions on the incidence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in the hospital.
    Leekha S, O'Hara LM, Sbarra A, Li S, Harris AD.
    Infect Control Hosp Epidemiol; 2020 Feb 15; 41(2):161-165. PubMed ID: 31896372
    [Abstract] [Full Text] [Related]

  • 19. Reduction in hospital-associated methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus with daily chlorhexidine gluconate bathing for medical inpatients.
    Lowe CF, Lloyd-Smith E, Sidhu B, Ritchie G, Sharma A, Jang W, Wong A, Bilawka J, Richards D, Kind T, Puddicombe D, Champagne S, Leung V, Romney MG.
    Am J Infect Control; 2017 Mar 01; 45(3):255-259. PubMed ID: 27938986
    [Abstract] [Full Text] [Related]

  • 20. Real-world experience of how chlorhexidine bathing affects the acquisition and incidence of vancomycin-resistant enterococci (VRE) in a medical intensive care unit with VRE endemicity: a prospective interrupted time-series study.
    Suh JW, Kim NH, Lee MJ, Lee SE, Chun BC, Lee CK, Lee J, Kim JH, Kim SB, Yoon YK, Sohn JW, Kim MJ.
    Antimicrob Resist Infect Control; 2021 Nov 10; 10(1):160. PubMed ID: 34758880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.